{"id":"https://openalex.org/W4363673867","doi":"https://doi.org/10.1186/s13075-023-03027-5","title":"Efficacy and safety of upadacitinib in patients with active psoriatic arthritis and axial involvement: results from two phase 3 studies","display_name":"Efficacy and safety of upadacitinib in patients with active psoriatic arthritis and axial involvement: results from two phase 3 studies","publication_year":2023,"publication_date":"2023-04-10","ids":{"openalex":"https://openalex.org/W4363673867","doi":"https://doi.org/10.1186/s13075-023-03027-5","pmid":"https://pubmed.ncbi.nlm.nih.gov/37038159","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/10084601"},"language":"en","primary_location":{"id":"doi:10.1186/s13075-023-03027-5","doi":"https://doi.org/10.1186/s13075-023-03027-5","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s13075-023-03027-5","pdf_url":"https://arthritis-research.biomedcentral.com/counter/pdf/10.1186/s13075-023-03027-5","source":{"id":"https://openalex.org/S149170128","display_name":"Arthritis Research & Therapy","issn_l":"1478-6354","issn":["1478-6354","1478-6362"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Arthritis Research &amp; Therapy","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://arthritis-research.biomedcentral.com/counter/pdf/10.1186/s13075-023-03027-5","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5064220409","display_name":"Xenofon Baraliakos","orcid":"https://orcid.org/0000-0002-9475-9362","observed_orcids":["https://orcid.org/0000-0002-9475-9362"]},"institutions":[{"id":"https://openalex.org/I4210091869","display_name":"Rheumazentrum Ruhrgebiet","ror":"https://ror.org/00e03sj10","country_code":"DE","type":"healthcare","lineage":["https://openalex.org/I2799784675","https://openalex.org/I4210088550","https://openalex.org/I4210091869"]},{"id":"https://openalex.org/I904495901","display_name":"Ruhr University Bochum","ror":"https://ror.org/04tsk2644","country_code":"DE","type":"education","lineage":["https://openalex.org/I904495901"]}],"countries":["DE"],"is_corresponding":true,"raw_author_name":"Xenofon Baraliakos","raw_affiliation_strings":["Rheumazentrum Ruhrgebiet, Ruhr-University Bochum, Claudiusstr. 45, 44649, Herne, Germany. xenofon.baraliakos@elisabethgruppe.de","Rheumazentrum Ruhrgebiet, Ruhr-University Bochum, Claudiusstr. 45, 44649, Herne, Germany"],"raw_orcid":"https://orcid.org/0000-0002-9475-9362","affiliations":[{"raw_affiliation_string":"Rheumazentrum Ruhrgebiet, Ruhr-University Bochum, Claudiusstr. 45, 44649, Herne, Germany. xenofon.baraliakos@elisabethgruppe.de","institution_ids":["https://openalex.org/I4210091869","https://openalex.org/I904495901"]},{"raw_affiliation_string":"Rheumazentrum Ruhrgebiet, Ruhr-University Bochum, Claudiusstr. 45, 44649, Herne, Germany","institution_ids":["https://openalex.org/I4210091869","https://openalex.org/I904495901"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085804957","display_name":"Roberto Ranza","orcid":"https://orcid.org/0000-0002-6855-2413","observed_orcids":["https://orcid.org/0000-0002-6855-2413"]},"institutions":[{"id":"https://openalex.org/I80850581","display_name":"Universidade Federal de Uberl\u00e2ndia","ror":"https://ror.org/04x3wvr31","country_code":"BR","type":"education","lineage":["https://openalex.org/I80850581"]}],"countries":["BR"],"is_corresponding":false,"raw_author_name":"Roberto Ranza","raw_affiliation_strings":["Servi\u00e7o de Reumatolog\u00eda, Hospital de Clinicas, Universidade Federal de Uberl\u00e2ndia, Uberl\u00e2ndia, Minas Gerais, Brazil"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Servi\u00e7o de Reumatolog\u00eda, Hospital de Clinicas, Universidade Federal de Uberl\u00e2ndia, Uberl\u00e2ndia, Minas Gerais, Brazil","institution_ids":["https://openalex.org/I80850581"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009877697","display_name":"Andrew J.K. \u00d6st\u00f6r","orcid":"https://orcid.org/0000-0002-7929-4827","observed_orcids":["https://orcid.org/0000-0002-7929-4827"]},"institutions":[{"id":"https://openalex.org/I4210093052","display_name":"Cabrini Hospital","ror":"https://ror.org/00qbkg805","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I4210093052"]},{"id":"https://openalex.org/I56590836","display_name":"Monash University","ror":"https://ror.org/02bfwt286","country_code":"AU","type":"education","lineage":["https://openalex.org/I56590836"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Andrew \u00d6st\u00f6r","raw_affiliation_strings":["Monash University, Cabrini Hospital & Emeritus Research, Melbourne & ANU, Canberra, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Monash University, Cabrini Hospital & Emeritus Research, Melbourne & ANU, Canberra, Australia","institution_ids":["https://openalex.org/I4210093052","https://openalex.org/I56590836"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5020328511","display_name":"Francesco Ciccia","orcid":"https://orcid.org/0000-0002-9352-1264","observed_orcids":["https://orcid.org/0000-0002-9352-1264"]},"institutions":[{"id":"https://openalex.org/I197809005","display_name":"University of Campania \"Luigi Vanvitelli\"","ror":"https://ror.org/02kqnpp86","country_code":"IT","type":"education","lineage":["https://openalex.org/I197809005"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Francesco Ciccia","raw_affiliation_strings":["University of Campania Luigi Vanvitelli, Caserta, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Campania Luigi Vanvitelli, Caserta, Italy","institution_ids":["https://openalex.org/I197809005"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085522760","display_name":"Laura C. Coates","orcid":"https://orcid.org/0000-0002-4756-663X","observed_orcids":["https://orcid.org/0000-0002-4756-663X"]},"institutions":[{"id":"https://openalex.org/I40120149","display_name":"University of Oxford","ror":"https://ror.org/052gg0110","country_code":"GB","type":"education","lineage":["https://openalex.org/I40120149"]}],"countries":["GB"],"is_corresponding":false,"raw_author_name":"Laura C. Coates","raw_affiliation_strings":["Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Nuffield Department of Orthopaedics, Rheumatology and Musculoskeletal Sciences, University of Oxford, Oxford, UK","institution_ids":["https://openalex.org/I40120149"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045319089","display_name":"Simona Rednic","orcid":"https://orcid.org/0000-0001-8149-7722","observed_orcids":["https://orcid.org/0000-0001-8149-7722"]},"institutions":[{"id":"https://openalex.org/I208470662","display_name":"Iuliu Ha\u021bieganu University of Medicine and Pharmacy","ror":"https://ror.org/051h0cw83","country_code":"RO","type":"education","lineage":["https://openalex.org/I208470662"]}],"countries":["RO"],"is_corresponding":false,"raw_author_name":"Simona Rednic","raw_affiliation_strings":["Rheumatology Department, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Rheumatology Department, Iuliu Hatieganu University of Medicine and Pharmacy, Cluj-Napoca, Romania","institution_ids":["https://openalex.org/I208470662"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033565189","display_name":"Jessica A. Walsh","orcid":"https://orcid.org/0000-0002-4563-0845","observed_orcids":["https://orcid.org/0000-0002-4563-0845"]},"institutions":[{"id":"https://openalex.org/I223532165","display_name":"University of Utah","ror":"https://ror.org/03r0ha626","country_code":"US","type":"education","lineage":["https://openalex.org/I223532165"]},{"id":"https://openalex.org/I2799886695","display_name":"Veterans Health Administration","ror":"https://ror.org/05eq41471","country_code":"US","type":"government","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695"]},{"id":"https://openalex.org/I4210089864","display_name":"VA Salt Lake City Healthcare System","ror":"https://ror.org/007fyq698","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1322918889","https://openalex.org/I2799886695","https://openalex.org/I4210089864","https://openalex.org/I4210113540"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jessica A. Walsh","raw_affiliation_strings":["Salt Lake City Veterans Affairs Health, Salt Lake City, UT, USA","University of Utah Health, Salt Lake City, UT, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Salt Lake City Veterans Affairs Health, Salt Lake City, UT, USA","institution_ids":["https://openalex.org/I2799886695","https://openalex.org/I4210089864"]},{"raw_affiliation_string":"University of Utah Health, Salt Lake City, UT, USA","institution_ids":["https://openalex.org/I223532165"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113043693","display_name":"Kevin Douglas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Kevin Douglas","raw_affiliation_strings":["AbbVie Inc, North Chicago, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AbbVie Inc, North Chicago, IL, USA","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5114106028","display_name":"Tianming Gao","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Tianming Gao","raw_affiliation_strings":["AbbVie Inc, North Chicago, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AbbVie Inc, North Chicago, IL, USA","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028379115","display_name":"Koji Kato","orcid":"https://orcid.org/0000-0002-5815-4585","observed_orcids":["https://orcid.org/0000-0002-5815-4585"]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Koji Kato","raw_affiliation_strings":["AbbVie Inc, North Chicago, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AbbVie Inc, North Chicago, IL, USA","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112024378","display_name":"In\u2010Ho Song","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2948539688","display_name":"AbbVie (United States)","ror":"https://ror.org/02g5p4n58","country_code":"US","type":"company","lineage":["https://openalex.org/I2948539688"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"In-Ho Song","raw_affiliation_strings":["AbbVie Inc, North Chicago, IL, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AbbVie Inc, North Chicago, IL, USA","institution_ids":["https://openalex.org/I2948539688"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112909636","display_name":"Fabiana Ganz","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Fabiana Ganz","raw_affiliation_strings":["AbbVie Inc, Baar, Switzerland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AbbVie Inc, Baar, Switzerland","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5111888136","display_name":"Atul A. Deodhar","orcid":"https://orcid.org/0000-0002-2130-1246","observed_orcids":["https://orcid.org/0000-0002-2130-1246"]},"institutions":[{"id":"https://openalex.org/I165690674","display_name":"Oregon Health & Science University","ror":"https://ror.org/009avj582","country_code":"US","type":"education","lineage":["https://openalex.org/I165690674"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Atul Deodhar","raw_affiliation_strings":["Oregon Health & Science University, Portland, OR, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Oregon Health & Science University, Portland, OR, USA","institution_ids":["https://openalex.org/I165690674"]}]}],"institutions":[],"countries_distinct_count":7,"institutions_distinct_count":13,"corresponding_author_ids":["https://openalex.org/A5064220409"],"corresponding_institution_ids":["https://openalex.org/I4210091869","https://openalex.org/I904495901"],"apc_list":{"value":3290,"currency":"USD","value_usd":3290},"apc_paid":{"value":3290,"currency":"USD","value_usd":3290},"fwci":2.613,"has_fulltext":true,"cited_by_count":15,"citation_normalized_percentile":{"value":0.90198113,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":95,"max":99},"biblio":{"volume":"25","issue":"1","first_page":"56","last_page":"56"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11092","display_name":"Spondyloarthritis Studies and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11092","display_name":"Spondyloarthritis Studies and Treatments","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10469","display_name":"Psoriasis: Treatment and Pathogenesis","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10200","display_name":"Rheumatoid Arthritis Research and Therapies","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2745","display_name":"Rheumatology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/upadacitinib","display_name":"upadacitinib","score":1.0},{"id":"https://openalex.org/keywords/psoriatic-arthritis","display_name":"psoriatic arthritis","score":0.996999979019165},{"id":"https://openalex.org/keywords/axial-involvement","display_name":"axial involvement","score":0.9909999966621399},{"id":"https://openalex.org/keywords/bath-ankylosing-spondylitis-disease-activity-index","display_name":"BASDAI","score":0.6700000166893005},{"id":"https://openalex.org/keywords/asdas","display_name":"ASDAS","score":0.8650000095367432},{"id":"https://openalex.org/keywords/adalimumab","display_name":"adalimumab","score":0.8560000061988831},{"id":"https://openalex.org/keywords/jak-inhibitors","display_name":"JAK inhibitors","score":0.6850000023841858},{"id":"https://openalex.org/keywords/disease-activity","display_name":"disease activity","score":0.5210000276565552},{"id":"https://openalex.org/keywords/treatment-emergent-adverse-events","display_name":"treatment-emergent adverse events","score":0.8600000143051147},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.4880000054836273},{"id":"https://openalex.org/keywords/patient-reported-outcomes","display_name":"patient-reported outcomes","score":0.6809999942779541}],"concepts":[{"id":"https://openalex.org/C2776260265","wikidata":"https://www.wikidata.org/wiki/Q511097","display_name":"Psoriatic arthritis","level":3,"score":0.8431351780891418},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8370110988616943},{"id":"https://openalex.org/C198451711","wikidata":"https://www.wikidata.org/wiki/Q327657","display_name":"Rheumatology","level":2,"score":0.7687207460403442},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5759150385856628},{"id":"https://openalex.org/C2777077863","wikidata":"https://www.wikidata.org/wiki/Q170990","display_name":"Arthritis","level":2,"score":0.41514265537261963},{"id":"https://openalex.org/C16005928","wikidata":"https://www.wikidata.org/wiki/Q171171","display_name":"Dermatology","level":1,"score":0.3843952417373657},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.3404502868652344}],"mesh":[{"descriptor_ui":"D000068879","descriptor_name":"Adalimumab","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D006575","descriptor_name":"Heterocyclic Compounds, 3-Ring","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D013167","descriptor_name":"Spondylitis, Ankylosing","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D015535","descriptor_name":"Arthritis, Psoriatic","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":6,"locations":[{"id":"doi:10.1186/s13075-023-03027-5","doi":"https://doi.org/10.1186/s13075-023-03027-5","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s13075-023-03027-5","pdf_url":"https://arthritis-research.biomedcentral.com/counter/pdf/10.1186/s13075-023-03027-5","source":{"id":"https://openalex.org/S149170128","display_name":"Arthritis Research & Therapy","issn_l":"1478-6354","issn":["1478-6354","1478-6362"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Arthritis Research &amp; Therapy","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:10084601","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/10084601","pdf_url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC10084601/pdf/13075_2023_Article_3027.pdf","source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Arthritis Res Ther","raw_type":"Text"},{"id":"pmid:37038159","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/37038159","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Arthritis research & therapy","raw_type":"Clinical Trial, Phase III"},{"id":"pmh:oai:ora.ox.ac.uk:uuid:69d27839-67dc-4348-8e4c-6e3a8037dcfd","doi":null,"is_oa":true,"landing_page_url":"https://ora.ox.ac.uk/objects/uuid:69d27839-67dc-4348-8e4c-6e3a8037dcfd","pdf_url":"https://ora.ox.ac.uk/objects/uuid:69d27839-67dc-4348-8e4c-6e3a8037dcfd/files/rjq085k80r","source":{"id":"https://openalex.org/S4306402636","display_name":"Oxford University Research Archive (ORA) (University of Oxford)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I40120149","host_organization_name":"University of Oxford","host_organization_lineage":["https://openalex.org/I40120149"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Symplectic Elements","raw_type":"Journal article"},{"id":"pmh:oai:doaj.org/article:90d18e6abacf401699f4e7aeeb68ccd1","doi":null,"is_oa":true,"landing_page_url":"https://doaj.org/article/90d18e6abacf401699f4e7aeeb68ccd1","pdf_url":null,"source":{"id":"https://openalex.org/S4306401280","display_name":"DOAJ (DOAJ: Directory of Open Access Journals)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by-sa","license_id":"https://openalex.org/licenses/cc-by-sa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Arthritis Research & Therapy, Vol 25, Iss 1, Pp 1-13 (2023)","raw_type":"article"},{"id":"pmh:oai:iris.unicampania.it:11591/497870","doi":null,"is_oa":false,"landing_page_url":"https://hdl.handle.net/11591/497870","pdf_url":null,"source":{"id":"https://openalex.org/S7407055255","display_name":"Archivio Istituzionale della Ricerca - Universit\u00e0 degli Studi della Campania \"Luigi Vanvitelli\"","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":null,"raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":{"id":"doi:10.1186/s13075-023-03027-5","doi":"https://doi.org/10.1186/s13075-023-03027-5","is_oa":true,"landing_page_url":"https://doi.org/10.1186/s13075-023-03027-5","pdf_url":"https://arthritis-research.biomedcentral.com/counter/pdf/10.1186/s13075-023-03027-5","source":{"id":"https://openalex.org/S149170128","display_name":"Arthritis Research & Therapy","issn_l":"1478-6354","issn":["1478-6354","1478-6362"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["anvur-scientific","cwts-core","doaj","dongbi-c","doyens","jufo-2","ki-jl-2","medline","norway-2","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320256","host_organization_name":"BioMed Central","host_organization_lineage":["https://openalex.org/P4310320256","https://openalex.org/P4310319965"],"host_organization_lineage_names":["BioMed Central","Springer Nature"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Arthritis Research &amp; Therapy","raw_type":"journal-article"},"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[{"id":"https://openalex.org/G3176667086","display_name":"Treating to target in psoriatic arthritis: assessing real-world outcomes and optimising therapeutic strategy for individuals.","funder_award_id":"CS-2016-16-016","funder_id":"https://openalex.org/F4320319990","funder_display_name":"National Institute for Health and Care Research"},{"id":"https://openalex.org/G4823534531","display_name":null,"funder_award_id":"CL-2011-02-001","funder_id":"https://openalex.org/F4320319990","funder_display_name":"National Institute for Health and Care Research"},{"id":"https://openalex.org/G4898905186","display_name":null,"funder_award_id":"AMS-SGCL9-Coates","funder_id":"https://openalex.org/F4320320241","funder_display_name":"Academy of Medical Sciences"}],"funders":[{"id":"https://openalex.org/F4320307105","display_name":"Amgen","ror":"https://ror.org/03g03ge92"},{"id":"https://openalex.org/F4320307115","display_name":"Bristol-Myers Squibb","ror":"https://ror.org/00gtmwv55"},{"id":"https://openalex.org/F4320307758","display_name":"Eli Lilly and Company","ror":"https://ror.org/01qat3289"},{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320307781","display_name":"Sanofi","ror":"https://ror.org/027vj4x92"},{"id":"https://openalex.org/F4320308573","display_name":"Gilead Sciences","ror":"https://ror.org/056546b03"},{"id":"https://openalex.org/F4320308604","display_name":"Biogen","ror":"https://ror.org/02jqkb192"},{"id":"https://openalex.org/F4320309086","display_name":"Celgene","ror":"https://ror.org/0527yg379"},{"id":"https://openalex.org/F4320319990","display_name":"National Institute for Health and Care Research","ror":"https://ror.org/0187kwz08"},{"id":"https://openalex.org/F4320320241","display_name":"Academy of Medical Sciences","ror":"https://ror.org/00c489v88"},{"id":"https://openalex.org/F4320327470","display_name":"Swedish Orphan Biovitrum","ror":"https://ror.org/04asvbz37"},{"id":"https://openalex.org/F4320328692","display_name":"Medac","ror":"https://ror.org/05e0gzh77"},{"id":"https://openalex.org/F4320333003","display_name":"Chugai Pharmaceutical","ror":"https://ror.org/01vepzj85"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4363673867.pdf","grobid_xml":"https://content.openalex.org/works/W4363673867.grobid-xml"},"referenced_works_count":31,"referenced_works":["https://openalex.org/W2083180635","https://openalex.org/W2411041938","https://openalex.org/W2558678787","https://openalex.org/W2807791746","https://openalex.org/W2808333862","https://openalex.org/W2810397534","https://openalex.org/W2945784486","https://openalex.org/W2946233321","https://openalex.org/W2961111920","https://openalex.org/W2980140632","https://openalex.org/W2988532979","https://openalex.org/W3041856700","https://openalex.org/W3092992115","https://openalex.org/W3109370940","https://openalex.org/W3109739095","https://openalex.org/W3138353584","https://openalex.org/W3147660541","https://openalex.org/W3157970781","https://openalex.org/W3159953466","https://openalex.org/W3173474932","https://openalex.org/W3173649223","https://openalex.org/W3175937533","https://openalex.org/W3205622799","https://openalex.org/W4200362431","https://openalex.org/W4210657972","https://openalex.org/W4283702087","https://openalex.org/W4283709118","https://openalex.org/W4283798749","https://openalex.org/W4288458053","https://openalex.org/W4288459194","https://openalex.org/W4306294863"],"related_works":["https://openalex.org/W4224310193","https://openalex.org/W4366832470","https://openalex.org/W6920945943","https://openalex.org/W4283702087","https://openalex.org/W3165592733","https://openalex.org/W4290997271","https://openalex.org/W3165823523","https://openalex.org/W3164450791","https://openalex.org/W4379649425","https://openalex.org/W3205622799"],"abstract_inverted_index":{"BACKGROUND:":[0],"The":[1],"objective":[2],"of":[3,14,27,70,79,83,138,168,201,236,319,327],"this":[4],"post-hoc":[5],"analysis":[6,26],"was":[7,58],"to":[8,36,43],"assess":[9],"the":[10,68,132],"efficacy":[11],"and":[12,30,77,85,89,97,111,184,206,221,231,247,275,304,310,344,351],"safety":[13],"upadacitinib":[15,37],"in":[16,33,131,163,203,208,257,292],"psoriatic":[17],"arthritis":[18],"(PsA)":[19],"patients":[20,34,139,169,202,237,333,363],"with":[21,186,240,289,299,312,334,347,364],"axial":[22,120,212,226,328,335,367],"involvement.":[23,368],"METHODS:":[24],"Post-hoc":[25],"SELECT-PsA":[28,31,53,204,209,258,293,372,375],"1":[29,54,205,259],"2":[32,210],"randomized":[35],"15":[38],"mg":[39,51],"(UPA15),":[40],"placebo":[41,243],"(switched":[42],"UPA15":[44,241,300,348],"at":[45,180,254,307,315],"week":[46,197,255,316],"24),":[47],"or":[48,64,94,136,166,174,365],"adalimumab":[49],"40":[50],"(ADA;":[52],"only).":[55],"Axial":[56],"involvement":[57,213,227,329,336],"determined":[59,337],"by":[60,214,228,338],"investigator":[61,95,215,229,251,274],"judgement":[62,96,216,230,252],"(yes":[63],"no;":[65],"based":[66],"on":[67],"totality":[69],"available":[71],"clinical":[72],"information,":[73],"such":[74,126,157],"as":[75,127,147,149,158],"duration":[76],"characteristics":[78],"back":[80],"pain,":[81],"age":[82],"onset,":[84],"previous":[86],"lab":[87],"investigations":[88],"imaging,":[90],"if":[91],"available)":[92],"alone,":[93,253],"patient-reported":[98],"outcome":[99],"(PRO)-based":[100],"criteria":[101,340],"(Bath":[102],"Ankylosing":[103,150],"Spondylitis":[104,151],"Disease":[105,152],"Activity":[106,153],"Index":[107],"[BASDAI]":[108],"\u2265":[109,114],"4":[110],"BASDAI":[112,124,134,303,343],"Q2":[113],"4).":[115],"Efficacy":[116],"outcomes":[117],"that":[118],"describe":[119],"disease":[121,173,176],"activity,":[122,177],"including":[123],"endpoints,":[125,156],"change":[128,160],"from":[129,145,161],"baseline":[130,162],"overall":[133,164],"score":[135],"proportion":[137,167],"achieving":[140,170],"BASDAI50":[141,239],"(\u2265":[142],"50%":[143],"improvement":[144],"baseline),":[146],"well":[148],"Score":[154],"(ASDAS)":[155],"mean":[159],"ASDAS":[165,171,305,345],"inactive":[172],"low":[175],"were":[178,297,321,359],"evaluated":[179],"weeks":[181,308],"12,":[182],"24,":[183,311],"56,":[185],"nominal":[187],"P-values":[188],"shown.":[189],"Treatment-emergent":[190],"adverse":[191],"events":[192],"(TEAEs)":[193],"are":[194],"summarized":[195],"through":[196],"56.":[198,317],"RESULTS:":[199],"30.9%":[200],"35.7%":[207],"had":[211,225],"alone;":[217],"22.6%":[218],"(SELECT-PsA":[219,223],"1)":[220],"28.6%":[222],"2)":[224],"PRO-based":[232],"criteria.":[233],"Greater":[234],"proportions":[235],"achieved":[238],"versus":[242,248,349,355],"using":[244,250],"either":[245],"criterion,":[246],"ADA":[249],"24":[256],"(investigator":[260],"alone:":[261],"UPA15,":[262,277],"59.0%,":[263],"placebo,":[264,279,350],"26.9%,":[265],"P":[266,271,281,286],"<":[267,282],"0.0001,":[268,283],"ADA,":[269,284],"44.1%,":[270],"=":[272,287],"0.015;":[273],"PRO-based:":[276],"60.4%,":[278],"29.3%,":[280],"47.1%,":[285],"0.074),":[288],"comparable":[290,361],"findings":[291],"2.":[294],"Similar":[295],"results":[296,358],"observed":[298],"for":[301],"additional":[302],"endpoints":[306],"12":[309],"improvements":[313],"maintained":[314],"Rates":[318],"TEAEs":[320],"generally":[322,360],"similar":[323],"across":[324],"sub-groups":[325],"irrespective":[326],"status.":[330],"CONCLUSIONS:":[331],"PsA":[332],"predefined":[339],"showed":[341],"greater":[342],"responses":[346,354],"numerically":[352],"similar/greater":[353],"ADA.":[356],"Safety":[357],"between":[362],"without":[366],"TRIAL":[369],"REGISTRATION:":[370],"ClinicalTrials.gov:":[371],"1,":[373],"NCT03104400;":[374],"2,":[376],"NCT0310437.":[377]},"counts_by_year":[{"year":2025,"cited_by_count":7},{"year":2024,"cited_by_count":5},{"year":2023,"cited_by_count":3}],"updated_date":"2026-11-09T13:22:03.289127","created_date":"2023-04-11T00:00:00"}